Insiders At Molina Healthcare Sold US$7.2m In Stock, Alluding To Potential Weakness
Insiders At Molina Healthcare Sold US$7.2m In Stock, Alluding To Potential Weakness
In the last year, many Molina Healthcare, Inc. (NYSE:MOH) insiders sold a substantial stake in the company which may have sparked shareholders' attention. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, shareholders should take a deeper look if several insiders are selling stock over a specific time period.
去年,許多Molina Healthcare, Inc.(紐約證券交易所代碼:MOH)內部人士出售了該公司的大量股份,這可能引起了股東的關注。在分析內幕交易時,了解內部人士是否在買入通常比知道他們是否在賣出更有價值,因爲後者發出的信息模棱兩可。但是,股東應更深入地研究是否有幾位內部人士在特定時間段內出售股票。
While insider transactions are not the most important thing when it comes to long-term investing, logic dictates you should pay some attention to whether insiders are buying or selling shares.
儘管在長期投資中,內幕交易並不是最重要的事情,但邏輯要求你應該注意內部人士是在買入還是賣出股票。
Check out our latest analysis for Molina Healthcare
查看我們對Molina Healthcare的最新分析
The Last 12 Months Of Insider Transactions At Molina Healthcare
Molina Healthcare 過去 12 個月的內幕交易
Over the last year, we can see that the biggest insider sale was by the Chief Legal Officer & Corporate Secretary, Jeffrey Barlow, for US$3.8m worth of shares, at about US$303 per share. That means that even when the share price was below the current price of US$360, an insider wanted to cash in some shares. When an insider sells below the current price, it suggests that they considered that lower price to be fair. That makes us wonder what they think of the (higher) recent valuation. Please do note, however, that sellers may have a variety of reasons for selling, so we don't know for sure what they think of the stock price. This single sale was just 16% of Jeffrey Barlow's stake.
去年,我們可以看到,最大的內幕交易是首席法務官兼公司秘書傑弗裏·巴洛以價值380萬美元的股票,每股約303美元。這意味着,即使股價低於目前的360美元,內部人士也想套現部分股票。當內部人士的賣出價格低於當前價格時,這表明他們認爲較低的價格是公平的。這讓我們想知道他們如何看待最近(更高的)估值。但是,請注意,賣家可能有各種各樣的賣出理由,因此我們不確定他們對股價的看法。這筆單筆交易僅佔傑弗裏·巴洛股份的16%。
In the last year Molina Healthcare insiders didn't buy any company stock. You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!
去年,Molina Healthcare內部人士沒有購買任何公司股票。您可以在下表中看到過去一年的內幕交易(由公司和個人進行的)。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!
![insider-trading-volume](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20231122/0-d6aab9cdc21fba624b68ee79103ff0cc-0-d3061aa5f43c74f6ab3051d97db373f8.png/big)
If you are like me, then you will not want to miss this free list of growing companies that insiders are buying.
如果你像我一樣,那麼你不會想錯過這份業內人士正在收購的成長型公司的免費名單。
Insiders At Molina Healthcare Have Sold Stock Recently
Molina Healthcare 的內部人士最近出售了股票
Over the last three months, we've seen significant insider selling at Molina Healthcare. In total, insiders dumped US$597k worth of shares in that time, and we didn't record any purchases whatsoever. Overall this makes us a bit cautious, but it's not the be all and end all.
在過去的三個月中,我們看到Molina Healthcare進行了大量的內幕拋售。在此期間,內部人士總共拋售了價值59.7萬美元的股票,我們沒有記錄任何買入記錄。總的來說,這讓我們有些謹慎,但這並不是萬能的。
Does Molina Healthcare Boast High Insider Ownership?
Molina Healthcare 是否擁有很高的內部所有權?
Looking at the total insider shareholdings in a company can help to inform your view of whether they are well aligned with common shareholders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. It's great to see that Molina Healthcare insiders own 1.1% of the company, worth about US$224m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.
查看公司的內部人持股總額可以幫助您了解他們是否與普通股股東保持良好關係。通常,內部人所有權越高,內部人士被激勵長期建立公司的可能性就越大。很高興看到Molina Healthcare內部人士擁有該公司1.1%的股份,價值約2.24億美元。內部人士持有這種重大所有權通常會增加公司爲所有股東的利益而經營的機會。
So What Does This Data Suggest About Molina Healthcare Insiders?
那麼,這些數據對莫利納醫療業內人士有何啓示呢?
Insiders sold Molina Healthcare shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. But since Molina Healthcare is profitable and growing, we're not too worried by this. While insiders do own a lot of shares in the company (which is good), our analysis of their transactions doesn't make us feel confident about the company. If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.
業內人士最近出售了Molina Healthcare的股票,但他們沒有買入任何股票。而且在過去的一年中,沒有任何可以給我們帶來安慰的購買。但是,由於Molina Healthcare盈利且正在增長,因此我們對此並不太擔心。儘管內部人士確實擁有該公司的大量股份(這很好),但我們對他們交易的分析並不能使我們對公司充滿信心。如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,你可以查看這份顯示分析師對其未來的預測的免費報告。
But note: Molina Healthcare may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但請注意:Molina Healthcare可能不是最值得買入的股票。因此,來看看這份免費列出的投資回報率高、債務低的有趣公司的名單。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。